CLINICAL PHARMACOLOGY OF FLUCONAZOLE IN NEONATES: EFFECTS AND PHARMACOKINETICS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

PACIFICI GIAN MARIA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Journal of Pediatric Perspectives Year:2016 | Volume:4 | Issue:3 Page(s): 1475-1489

Download Full-Text

View:

300

Download:

318

Cites:

Information Journal Paper

Title

CLINICAL PHARMACOLOGY OF FLUCONAZOLE IN NEONATES: EFFECTS AND PHARMACOKINETICS

Author(s)

PACIFICI GIAN MARIA | Issue Writer Certificate

Keywords

EFFECTS

FLUCONAZOLE

NEONATES

PHARMACOKINETICS

Abstract

Fluconazole is commonly used both to prevent and to treat invasive neonatal Candida albicans infection. This drug is a potent, selective, triazole inhibitor of the fungal enzymes involved in ergosterol synthesis. It is largely excreted unchanged in the urine. In infants with a birth weight<1, 500 grams, fungal infection is approximately 3% to 4%. Up to 30% of infants with invasive candidiasis die. Penetration into the cerebral spinal is good. While high-dose systemic exposure of 400 mg/day in the first trimester of pregnancy can produce serious fetal abnormalities a single dose of 150 mg of FLUCONAZOLE does not produce fetal abnormalities. The FLUCONAZOLE exposure target AUC of ≥400 mg.h/ml should be reached and a dosage of 12 mg/kg/day is recommended. However, to reach the desired FLUCONAZOLE concentration a loading dose of 25 mg/kg of FLUCONAZOLE is used in patients with candidiasis on the first day of therapy. The half-life of FLUCONAZOLE ranges from 25.5 to 88.6 hours while adults it is 32 hours. In prematures, the half-life of FLUCONAZOLE is 88.6, 67.5 and 55.2 hours, in the first day, in the first week and in the second week of life, respectively. The clearance of FLUCONAZOLE ranges from 0.27 to 0.52 ml/min/kg and the adults it is 0.27 ml/min/kg. The distribution volume of FLUCONAZOLE ranges from 1.1 to 2.4 l/kg and in adults it is 0.60 l/kg. The aim of this study is to review the EFFECTS and PHARMACOKINETICS of FLUCONAZOLE in NEONATES.

Cites

No record.

References

No record.

Cite

APA: Copy

PACIFICI, GIAN MARIA. (2016). CLINICAL PHARMACOLOGY OF FLUCONAZOLE IN NEONATES: EFFECTS AND PHARMACOKINETICS. INTERNATIONAL JOURNAL OF PEDIATRICS, 4(3), 1475-1489. SID. https://sid.ir/paper/337186/en

Vancouver: Copy

PACIFICI GIAN MARIA. CLINICAL PHARMACOLOGY OF FLUCONAZOLE IN NEONATES: EFFECTS AND PHARMACOKINETICS. INTERNATIONAL JOURNAL OF PEDIATRICS[Internet]. 2016;4(3):1475-1489. Available from: https://sid.ir/paper/337186/en

IEEE: Copy

GIAN MARIA PACIFICI, “CLINICAL PHARMACOLOGY OF FLUCONAZOLE IN NEONATES: EFFECTS AND PHARMACOKINETICS,” INTERNATIONAL JOURNAL OF PEDIATRICS, vol. 4, no. 3, pp. 1475–1489, 2016, [Online]. Available: https://sid.ir/paper/337186/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops